Stannous fluoride reduction of gingivitis, gingival bleeding supported by studies, P&G says.
This article was originally published in The Rose Sheet
Executive Summary
STANNOUS FLUORIDE REDUCTION OF GINGIVITIS, GINGIVAL BLEEDING is supported by clinical studies involving more than 2,000 subjects, Procter & Gamble said in a presentation to FDA's Dental Products Panel's Plaque Subcommittee April 11. P&G Clinical Research Section Head Stephen McClanahan, PhD, reviewed the results of six randomized, double-blinded, longitudinal studies with parallel treatment groups in support of the ingredient's antigingivitis properties.